Project Details
| Status | Finished |
|---|---|
| Effective start/end date | 2/8/06 → 3/1/12 |
Funding
- Ingenix Pharmaceutical Services, Inc. (CLI-037 // CLI-037)
- Vion Pharmaceuticals, Inc. (CLI-037 // CLI-037)
Prot# CLI-037: A Phase III Randomized Study of CLORETAZINE (VNP40101M) and Cytosine Arabinoside (AraC) in Patients with Acute Myeloid Leukemia in First Relapse
- Tallman, Martin Stuart (PD/PI)
Project: Research project